← Leaderboards
Andrew D Badley
Mayo Clinic Rochester
$16,248,519
Attributed
$16,248,519
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,248,519 · 9
By mechanism
R01$13,668,939 · 4
R56$2,287,580 · 4
R21$292,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Zhenkun Lou$18,569,951
- Cornelia M Weyand$30,789,284
- Justin L. Mott$4,114,486
- Scott H Kaufmann$29,002,745
- Nathan William Cummins$397,500
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCell DeathCellsImmuneCd4 Positive T LymphocytesHiv InfectionsCessation Of LifeSignal TransductionInfectionProteinsViralApoptoticT-LymphocyteCell KillingBaseIn VivoRegulationStimulusResistanceResponseVirusImmune ResponseMediatingCell Physiology
Grant awards (33)
Prime shock and kill for HIV erradication$752,862
R01 · FY2024 · AI · contact PI
IMPACT OF BCL2 PHOSPHORYLATION ON HIV DYNAMICS, RESERVOIR SIZE AND SUSCEPTIBILITY TO VENETOCLAX$682,446
R56 · FY2024 · AI · contact PI
Prime shock and kill for HIV erradication$752,862
R01 · FY2022 · AI · contact PI
Prime shock and kill for HIV erradication$752,862
R01 · FY2021 · AI · contact PI
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence$606,874
R56 · FY2021 · AI · contact PI
Prime shock and kill for HIV erradication$752,862
R01 · FY2020 · AI · contact PI
Prime shock and kill for HIV erradication$752,862
R01 · FY2019 · AI · contact PI
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.$505,728
R01 · FY2019 · AI · contact PI
Prime shock and kill for HIV erradication$690,241
R01 · FY2018 · AI · contact PI
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.$505,728
R01 · FY2018 · AI · contact PI
Prime shock and kill for HIV erradication$690,241
R01 · FY2017 · AI · contact PI
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.$505,728
R01 · FY2017 · AI · contact PI
Prime shock and kill for HIV erradication$690,241
R01 · FY2016 · AI · contact PI
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.$505,728
R01 · FY2016 · AI · contact PI
Prime shock and kill for HIV erradication$555,091
R01 · FY2015 · AI · contact PI
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.$505,728
R01 · FY2015 · AI · contact PI
Prime shock and kill for HIV erradication$555,091
R01 · FY2014 · AI · contact PI
Enhancing control of HIV by inhibiting TRAILshort$539,632
R56 · FY2013 · AI · contact PI
Regulation of HIV-Mediated CD4 T Cell Apoptosis$458,628
R56 · FY2012 · AI · contact PI
Regulation of HIV-Mediated CD4 T Cell Apoptosis$355,748
R01 · FY2011 · AI · contact PI
Regulation of HIV-Mediated CD4 T Cell Apoptosis$359,341
R01 · FY2010 · AI · contact PI
Regulation of HIV-Mediated CD4 T Cell Apoptosis$362,970
R01 · FY2009 · AI · contact PI
Regulation of HIV-Mediated CD4 T Cell Apoptosis$362,970
R01 · FY2008 · AI · contact PI
Procaspase 8 Activation by HIV Protease$308,700
R01 · FY2008 · AI · contact PI
Regulation of HIV-Mediated CD4 T Cell Apoptosis$370,000
R01 · FY2007 · AI · contact PI
Procaspase 8 Activation by HIV Protease$314,678
R01 · FY2007 · AI · contact PI
Procaspase 8 Activation by HIV Protease$324,077
R01 · FY2006 · AI · contact PI
Procaspase 8 Activation by HIV Protease$331,875
R01 · FY2005 · AI
REGULATION OF HIV-MEDIATED CD4 T CELL APOPTOSIS$282,200
R01 · FY2005 · AI
REGULATION OF HIV-MEDIATED CD4 T CELL APOPTOSIS$282,200
R01 · FY2004 · AI
Procaspase 8 Activation by HIV Protease$258,125
R01 · FY2004 · AI
Significance of HIV Protease Cleavage of Procaspase 8$292,000
R21 · FY2003 · AI
REGULATION OF HIV-MEDIATED CD4 T CELL APOPTOSIS$282,200
R01 · FY2003 · AI